Medical Therapy for Vitiligo: Innovations and Treatments

Terry Paso from Nice University Hospital discusses the evolving landscape of medical therapy for vitiligo, highlighting the complexities involved in treating the condition. Unlike psoriasis, which can be relieved by targeting inflammation, vitiligo treatment requires altering pigmentation through immune modulation and promoting melanocyte stem cell differentiation. He emphasizes the necessity of early intervention to halt depigmentation, primarily using combined narrowband UVB and systemic treatments like metin prednisolone. Treatments, including topical corticosteroids and newer therapies like ruxolitinib and baricitinib, show promise, with better results seen when combined with UV exposure. Paso highlights the importance of patient education regarding the timeline for seeing treatment effects, often taking 6 to 24 months. He notes that, while recent innovations show efficacy, especially for facial depigmentation, achieving significant results for challenging areas like the hands and feet remains difficult. Ongoing studies with additional therapies are anticipated to provide improved outcomes in the future, reflecting the hope that multi-modal approaches will enhance treatment effectiveness for vitiligo.